mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
8e-10 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-09 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-07 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
1e-07 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-07 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
3e-07 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-07 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-06 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |